PET measurements of myocardial blood flow in normal subjects
| Author | Tracer | Agent | Number subjects | Age | MBFbas | MBFhyp | MBFhyp/bas |
| Bergmann et al | H2 15O | Dip | 11 | 25 | 0.9 (0.2) | 3.6 (1.2) | 4.1 (1.2) |
| Geltman et al | H2 15O | Dip | 16 | 25 (4) | 1.2 (0.3) | 4.6 (1.6) | 3.8 (1.1) |
| Camiciet al | 13NH3 | Dip | 12 | 51 (8) | 1.0 (0.2) | 2.7 (0.9) | 2.9 (1.0) |
| Sambucetiet al | 13NH3 | Dip | 14 | 49 (7) | 1.1 (0.3 | 3.7 (0.8 | 3.6 (0.9 |
| Chan et al | 13NH3 | Ado | 20 | 35 (16) | 1.1 (0.2) | 4.4 (0.9) | 4.4 (1.5) |
| Chanet al | 13NH3 | Dip | 20 | 35 (16) | 1.1 (0.2) | 4.3 (1.3) | 4.3 (1.9) |
| Araujoet al | C15O2 | Dip | 11 | 26 to 42 | 0.8 (0.1) | 3.5 (1.1) | 4.2 (1.2) |
| Merletet al | H2 15O | Dip | 6 | 51 (5) | 0.9 (0.1) | 3.5 (0.8) | 4.0 (0.7) |
| Muziket al | 13NH3 | Ado | 6 | 26 (3) | 0.8 (0.2) | 3.6 (1.0) | |
| Uren et al | H2 15O | Dip/Ado | 43 | 47 (20 | 1.0 (0.2) | 3.2 (1.3) | 3.4 (1.3) |
| Radvanet al | C15O2 | Dip | 8 | 27 (5) | 0.8 (0.2) | 3.1 (08) | 3.8 (0.8) |
| Czerninet al | 13NH3 | Dip | 18 | 31 (9) | 0.8 (0.2) | 3.0 (0.8) | 4.1 (0.9) |
| Czerninet al | 13NH3 | Dip | 22 | 64 (9) | 0.9 (0.3) | 2.7 (0.6) | 3.0 (0.7) |
Ado, adenosine; Dip, dipyridamole; MBFbas, baseline myocardial blood flow; MBFhyp, hyperaemic myocardial blood flow; MBFhyp/bas, coronary flow reserve. Data are mean (SD). Adapted from Camici et al.5